SUBVENITE 150 MG TABLET
FDA nonproprietary name: lamotrigine
For 30 tablets
Pharmacies pay
$2.08 filed
30 × $0.06947 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare
We don’t know yet
No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.
The spread
We don’t know yet
There is no Medicare figure to compare with, so there is no spread.
Cost-plus estimate
$7.39 estimated
$2.08 + $0.31 (15%) + $5.00 fee per fill = $7.39
This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
SUBVENITE 150 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as lamotrigine, under the trade name “SUBVENITE”.
FDA gives its dosage form as tablet and its route as oral.
The labeler, the company named on the label, is OWP Pharmaceuticals, Inc.
FDA lists it under 2 Established Pharmacologic Classes: Anti-epileptic Agent and Mood Stabilizer.
The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 69102-0150-06.
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $2.08 for 30 tablets (30 × $0.06947 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
What NADAC measures · Why 30 tablets · NADAC explanation codes
The NDC
- 69102-0150-06 · OWP Pharmaceuticals, Inc. · $0.06947 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
36 other products in the NADAC file share the FDA nonproprietary name lamotrigine with SUBVENITE 150 MG TABLET. The 23 below share a strength or dosage form with it first; search OpenBill for the rest.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| LAMICTAL 25 MG DISPER TABLET | $11.18289 per EA filed | $11.42567 per EA filed |
| LAMICTAL 25 MG TABLET | $10.29501 per EA filed | $11.42567 per EA filed |
| LAMICTAL 100 MG TABLET | $10.91795 per EA filed | $11.42567 per EA filed |
| LAMICTAL 150 MG TABLET | $11.4684 per EA filed | $11.42567 per EA filed |
| LAMICTAL 200 MG TABLET | $12.05122 per EA filed | $11.42567 per EA filed |
| LAMICTAL ODT 25 MG TABLET | $12.81313 per EA filed | $15.99002 per EA filed |
| LAMICTAL ODT 50 MG TABLET | $13.65287 per EA filed | $15.99002 per EA filed |
| LAMICTAL ODT 100 MG TABLET | $14.63582 per EA filed | $15.99002 per EA filed |
| LAMICTAL ODT 200 MG TABLET | $17.48893 per EA filed | $15.99002 per EA filed |
| LAMICTAL XR 25 MG TABLET | $14.2042 per EA filed | $34.14263 per EA filed |
| LAMICTAL XR 100 MG TABLET | $30.40041 per EA filed | $34.14263 per EA filed |
| LAMICTAL XR 200 MG TABLET | $32.33073 per EA filed | $34.14263 per EA filed |
| LAMOTRIGINE 25 MG TABLET | $0.02676 per EA filed | $0.16656 per EA filed |
| LAMOTRIGINE 100 MG TABLET | $0.04873 per EA filed | $0.16656 per EA filed |
| LAMOTRIGINE 150 MG TABLET | $0.06947 per EA filed | $0.16656 per EA filed |
| LAMOTRIGINE 200 MG TABLET | $0.08253 per EA filed | $0.16656 per EA filed |
| LAMOTRIGINE ODT 25 MG TABLET | $1.29941 per EA filed | $4.459 per EA filed |
| LAMOTRIGINE ODT 50 MG TABLET | $1.27096 per EA filed | $4.459 per EA filed |
| LAMOTRIGINE ODT 100 MG TABLET | $1.62503 per EA filed | $4.459 per EA filed |
| LAMOTRIGINE ODT 200 MG TABLET | $1.64336 per EA filed | $4.459 per EA filed |
| SUBVENITE 25 MG TABLET | $0.02676 per EA filed | We don’t know yet |
| SUBVENITE 100 MG TABLET | $0.04873 per EA filed | We don’t know yet |
| SUBVENITE 150 MG TABLET this page | $0.06947 per EA filed | We don’t know yet |
| SUBVENITE 200 MG TABLET | $0.08253 per EA filed | We don’t know yet |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-05-20, 2026-09-23, 2026-09-30 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
Its NADAC price is $0.06947 per EA filed.
Of the 85 other products in FDA’s Anti-epileptic Agent class priced per EA, 77 have a higher middle NADAC price and 7 a lower one; 1 has the same. The one in the middle is PHENYTEK 200 MG CAPSULE, at $1.4026 per EA filed (eff. 2026-09-23).
Of the 72 other products in FDA’s Mood Stabilizer class priced per EA, 66 have a higher middle NADAC price and 5 a lower one; 1 has the same. The one in the middle is LAMOTRIGINE ODT 50 MG TABLET, at $1.27096 per EA filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
We don’t know yet; the card above says why.
Which Medicare figure OpenBill compares · How Part D is matched · How Part B is matched
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Related pages
Its pharmacologic classes
Related in the same class
- DIVALPROEX SOD ER 250 MG TAB
- VALPROIC ACID 250 MG CAPSULE
- GABAPENTIN 600 MG TABLET
- PRIMIDONE 125 MG TABLET
- LITHIUM CARBONATE 300 MG TAB